157 related articles for article (PubMed ID: 33901643)
1. Discovery of boronic acid-based potent activators of tumor pyruvate kinase M2 and development of gastroretentive nanoformulation for oral dosing.
Patle R; Shinde S; Patel S; Maheshwari R; Jariyal H; Srivastava A; Chauhan N; Globisch C; Jain A; Tekade RK; Shard A
Bioorg Med Chem Lett; 2021 Jun; 42():128062. PubMed ID: 33901643
[TBL] [Abstract][Full Text] [Related]
2. Boronic acid derivative activates pyruvate kinase M2 indispensable for redox metabolism in oral cancer cells.
Rihan M; Vineela Nalla L; Dharavath A; Patel S; Shard A; Khairnar A
Bioorg Med Chem Lett; 2022 Mar; 59():128539. PubMed ID: 35007726
[TBL] [Abstract][Full Text] [Related]
3. Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators.
Li R; Ning X; Zhou S; Lin Z; Wu X; Chen H; Bai X; Wang X; Ge Z; Li R; Yin Y
Eur J Med Chem; 2018 Jan; 143():48-65. PubMed ID: 29172082
[TBL] [Abstract][Full Text] [Related]
4. Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity.
Chen C; Wang T; Wu F; Huang W; He G; Ouyang L; Xiang M; Peng C; Jiang Q
Drug Des Devel Ther; 2014; 8():1195-210. PubMed ID: 25214764
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2).
Xu Y; Liu XH; Saunders M; Pearce S; Foulks JM; Parnell KM; Clifford A; Nix RN; Bullough J; Hendrickson TF; Wright K; McCullar MV; Kanner SB; Ho KK
Bioorg Med Chem Lett; 2014 Jan; 24(2):515-9. PubMed ID: 24374270
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators.
Li R; Ning X; He J; Lin Z; Su Y; Li R; Yin Y
Bioorg Chem; 2021 Mar; 108():104653. PubMed ID: 33517002
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors.
Liu B; Yuan X; Xu B; Zhang H; Li R; Wang X; Ge Z; Li R
Eur J Med Chem; 2019 May; 170():1-15. PubMed ID: 30878825
[TBL] [Abstract][Full Text] [Related]
8. Knowledge-driven design and optimization of potent symmetric anticancer molecules: A case study on PKM2 activators.
Jaiswal E; Globisch C; Jain A
Comput Biol Med; 2022 Dec; 151(Pt B):106313. PubMed ID: 36450217
[TBL] [Abstract][Full Text] [Related]
9. Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia.
Li J; Li S; Guo J; Li Q; Long J; Ma C; Ding Y; Yan C; Li L; Wu Z; Zhu H; Li KK; Wen L; Zhang Q; Xue Q; Zhao C; Liu N; Ivanov I; Luo M; Xi R; Long H; Wang PG; Chen Y
J Med Chem; 2018 May; 61(9):4155-4164. PubMed ID: 29641204
[TBL] [Abstract][Full Text] [Related]
10. Activators of PKM2 in cancer metabolism.
Warner SL; Carpenter KJ; Bearss DJ
Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
[TBL] [Abstract][Full Text] [Related]
11. Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far?
Chhipa AS; Patel S
Life Sci; 2021 Sep; 280():119694. PubMed ID: 34102192
[TBL] [Abstract][Full Text] [Related]
12. The cysteine residue at 424th of pyruvate kinase M2 is crucial for tetramerization and responsiveness to oxidative stress.
Masaki S; Hashimoto K; Kihara D; Tsuzuki C; Kataoka N; Suzuki K
Biochem Biophys Res Commun; 2020 Jun; 526(4):973-977. PubMed ID: 32295714
[TBL] [Abstract][Full Text] [Related]
13. Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator.
Matsui Y; Yasumatsu I; Asahi T; Kitamura T; Kanai K; Ubukata O; Hayasaka H; Takaishi S; Hanzawa H; Katakura S
Bioorg Med Chem; 2017 Jul; 25(13):3540-3546. PubMed ID: 28511909
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase activators as a therapy target: a patent review 2011-2017.
Adem S; Comakli V; Uzun N
Expert Opin Ther Pat; 2018 Jan; 28(1):61-68. PubMed ID: 28994333
[TBL] [Abstract][Full Text] [Related]
15. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications.
Chen P; Lou L; Sharma B; Li M; Xie C; Yang F; Wu Y; Xiao Q; Gao L
Curr Med Chem; 2024; 31(20):2955-2973. PubMed ID: 37455458
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators.
Guo C; Linton A; Jalaie M; Kephart S; Ornelas M; Pairish M; Greasley S; Richardson P; Maegley K; Hickey M; Li J; Wu X; Ji X; Xie Z
Bioorg Med Chem Lett; 2013 Jun; 23(11):3358-63. PubMed ID: 23622982
[TBL] [Abstract][Full Text] [Related]
19. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
[TBL] [Abstract][Full Text] [Related]
20. Small molecule activation of PKM2 in cancer cells induces serine auxotrophy.
Kung C; Hixon J; Choe S; Marks K; Gross S; Murphy E; DeLaBarre B; Cianchetta G; Sethumadhavan S; Wang X; Yan S; Gao Y; Fang C; Wei W; Jiang F; Wang S; Qian K; Saunders J; Driggers E; Woo HK; Kunii K; Murray S; Yang H; Yen K; Liu W; Cantley LC; Vander Heiden MG; Su SM; Jin S; Salituro FG; Dang L
Chem Biol; 2012 Sep; 19(9):1187-98. PubMed ID: 22999886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
